See more : Mid Wynd International Investment Trust plc (MWY.L) Income Statement Analysis – Financial Results
Complete financial analysis of COSMOS Pharmaceutical Corporation (3349.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of COSMOS Pharmaceutical Corporation, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Domain Holdings Australia Limited (DHGAF) Income Statement Analysis – Financial Results
- Zhuzhou CRRC Times Electric Co., Ltd. (ZHUZY) Income Statement Analysis – Financial Results
- Semac Consultants Limited (SEMAC.BO) Income Statement Analysis – Financial Results
- Sunteck Realty Limited (SUNTECK.BO) Income Statement Analysis – Financial Results
- Emperor Capital Group Limited (0717.HK) Income Statement Analysis – Financial Results
COSMOS Pharmaceutical Corporation (3349.T)
About COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. It also operates 1,130 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was founded in 1983 and is headquartered in Fukuoka, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 964.99B | 827.70B | 755.41B | 726.42B | 684.40B | 611.14B | 558.00B | 502.73B | 447.27B | 408.47B | 371.83B | 329.31B | 279.02B | 237.17B | 205.39B | 177.76B | 148.24B | 125.85B | 105.05B | 78.65B |
| Cost of Revenue | 776.68B | 658.98B | 603.97B | 581.31B | 549.42B | 489.35B | 447.68B | 402.69B | 360.42B | 330.39B | 301.27B | 267.53B | 226.04B | 191.67B | 165.32B | 141.74B | 115.55B | 97.49B | 81.76B | 60.94B |
| Gross Profit | 188.31B | 168.72B | 151.45B | 145.11B | 134.98B | 121.78B | 110.32B | 100.04B | 86.85B | 78.08B | 70.56B | 61.79B | 52.99B | 45.50B | 40.06B | 36.02B | 32.70B | 28.36B | 23.29B | 17.71B |
| Gross Profit Ratio | 19.51% | 20.38% | 20.05% | 19.98% | 19.72% | 19.93% | 19.77% | 19.90% | 19.42% | 19.11% | 18.98% | 18.76% | 18.99% | 19.19% | 19.51% | 20.26% | 22.06% | 22.53% | 22.17% | 22.52% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 116.00M | 128.00M | 127.00M | 129.00M | 127.00M | 128.00M | 129.00M | 118.00M | 117.00M | 116.00M | 119.00M | 127.00M | 0.00 | 0.00 | 0.00 | 0.00 | 3.98B | 4.60B | 3.88B | 3.11B |
| Selling & Marketing | 1.81B | 1.65B | 1.63B | 2.78B | 4.27B | 3.77B | 1.84B | 1.82B | 1.69B | 1.78B | 1.65B | 1.30B | 0.00 | 0.00 | 0.00 | 0.00 | 1.22B | 929.00M | 896.00M | 764.00M |
| SG&A | 138.54B | 122.81B | 107.76B | 99.16B | 93.35B | 85.05B | 76.68B | 68.10B | 59.44B | 54.10B | 48.52B | 42.09B | 0.00 | 0.00 | 0.00 | 0.00 | 5.20B | 5.53B | 4.78B | 3.87B |
| Other Expenses | 18.27B | 2.96B | 3.07B | 2.74B | 2.55B | 2.52B | 2.52B | 2.37B | 2.04B | 1.62B | 1.44B | 1.21B | 1.16B | 1.04B | 1.10B | 802.00M | 688.00M | 652.00M | 476.00M | 291.00M |
| Operating Expenses | 156.81B | 138.59B | 121.65B | 111.96B | 105.89B | 97.01B | 87.57B | 77.81B | 68.21B | 60.99B | 53.85B | 46.26B | 39.66B | 35.46B | 32.32B | 30.58B | 27.89B | 24.59B | 19.88B | 15.46B |
| Cost & Expenses | 933.49B | 797.57B | 725.62B | 693.28B | 655.31B | 586.36B | 535.25B | 480.49B | 428.63B | 391.38B | 355.12B | 313.78B | 265.69B | 227.13B | 197.64B | 172.32B | 143.44B | 122.08B | 101.64B | 76.39B |
| Interest Income | 44.00M | 47.00M | 52.00M | 57.00M | 65.00M | 72.00M | 78.00M | 85.00M | 91.00M | 93.00M | 97.00M | 102.00M | 109.00M | 110.00M | 103.00M | 108.00M | 90.00M | 62.00M | 44.00M | 33.00M |
| Interest Expense | 99.00M | 51.00M | 52.00M | 60.00M | 69.00M | 77.00M | 88.00M | 98.00M | 91.00M | 55.00M | 50.00M | 57.00M | 81.00M | 116.00M | 141.00M | 130.00M | 120.00M | 101.00M | 88.00M | 116.00M |
| Depreciation & Amortization | 19.92B | 17.37B | 15.11B | 13.79B | 13.56B | 12.96B | 11.89B | 10.71B | 9.59B | 7.34B | 5.60B | 4.25B | 3.10B | 2.36B | 1.86B | 1.42B | 1.03B | 844.00M | 634.00M | 418.00M |
| EBITDA | 53.74B | 47.50B | 44.91B | 46.93B | 42.66B | 37.73B | 34.64B | 32.95B | 28.24B | 24.42B | 22.31B | 20.96B | 17.58B | 13.05B | 10.75B | 6.88B | 5.28B | 5.27B | 4.44B | 2.94B |
| EBITDA Ratio | 5.57% | 6.10% | 6.36% | 6.85% | 6.61% | 6.60% | 6.67% | 7.04% | 6.79% | 6.47% | 6.41% | 6.40% | 6.34% | 5.71% | 5.26% | 4.37% | 4.46% | 4.23% | 4.34% | 3.81% |
| Operating Income | 31.50B | 30.13B | 29.80B | 33.15B | 29.09B | 24.78B | 22.75B | 22.24B | 18.65B | 17.08B | 16.71B | 15.53B | 13.33B | 10.04B | 7.74B | 5.44B | 4.81B | 3.76B | 3.41B | 2.26B |
| Operating Income Ratio | 3.26% | 3.64% | 3.94% | 4.56% | 4.25% | 4.05% | 4.08% | 4.42% | 4.17% | 4.18% | 4.49% | 4.72% | 4.78% | 4.23% | 3.77% | 3.06% | 3.24% | 2.99% | 3.24% | 2.87% |
| Total Other Income/Expenses | 2.22B | 2.65B | 3.25B | 5.45B | 1.31B | 2.36B | 2.42B | 3.50B | 1.85B | 2.34B | 1.71B | 1.12B | 1.07B | 529.00M | 1.01B | -113.00M | -677.00M | 558.00M | 311.00M | 143.00M |
| Income Before Tax | 33.72B | 32.77B | 33.05B | 38.60B | 30.40B | 27.14B | 25.17B | 25.74B | 20.50B | 19.42B | 18.42B | 16.65B | 14.40B | 10.57B | 8.76B | 5.33B | 4.13B | 4.32B | 3.72B | 2.40B |
| Income Before Tax Ratio | 3.49% | 3.96% | 4.37% | 5.31% | 4.44% | 4.44% | 4.51% | 5.12% | 4.58% | 4.75% | 4.95% | 5.06% | 5.16% | 4.46% | 4.26% | 3.00% | 2.79% | 3.43% | 3.54% | 3.05% |
| Income Tax Expense | 9.27B | 8.98B | 9.89B | 11.44B | 8.97B | 7.95B | 7.53B | 7.52B | 8.06B | 7.73B | 7.82B | 7.26B | 6.66B | 4.83B | 4.04B | 2.48B | 1.96B | 2.02B | 1.78B | 1.14B |
| Net Income | 24.45B | 23.80B | 23.16B | 27.16B | 21.44B | 19.19B | 17.63B | 18.22B | 12.44B | 11.69B | 10.60B | 9.40B | 7.74B | 5.74B | 4.71B | 2.84B | 2.17B | 2.30B | 1.94B | 1.26B |
| Net Income Ratio | 2.53% | 2.88% | 3.07% | 3.74% | 3.13% | 3.14% | 3.16% | 3.62% | 2.78% | 2.86% | 2.85% | 2.85% | 2.77% | 2.42% | 2.29% | 1.60% | 1.47% | 1.83% | 1.85% | 1.60% |
| EPS | 308.61 | 300.48 | 292.37 | 342.89 | 270.65 | 242.24 | 222.64 | 229.99 | 157.01 | 147.65 | 133.84 | 237.28 | 195.39 | 144.90 | 119.00 | 71.76 | 54.49 | 57.48 | 51.03 | 74.79 |
| EPS Diluted | 308.61 | 300.48 | 292.37 | 342.89 | 270.65 | 242.24 | 222.64 | 229.99 | 157.01 | 147.65 | 133.84 | 237.28 | 195.39 | 144.90 | 119.00 | 71.76 | 54.49 | 57.48 | 51.03 | 74.79 |
| Weighted Avg Shares Out | 79.24M | 79.20M | 79.20M | 79.20M | 79.20M | 79.20M | 79.20M | 79.20M | 79.20M | 79.20M | 79.20M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.89M | 40.00M | 38.11M | 16.58M |
| Weighted Avg Shares Out (Dil) | 79.24M | 79.20M | 79.20M | 79.20M | 79.20M | 79.20M | 79.20M | 79.20M | 79.20M | 79.20M | 79.20M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.89M | 40.00M | 38.11M | 16.58M |
No news found for: 3349.T
Source: https://incomestatements.info
Category: Stock Reports